Article
Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal Transition
2019-12-26
Abstract excerpt
<h4>ABSTRACT</h4> <h4>BACKGROUND AND AIMS</h4> Methotrexate is an important tool in the arsenal of oncologists, gastroenterologists, and rheumatologists. At low doses it induces intestinal barrier dysfunction that may induce side effects such as gastrointestinal discomfort and liver injury. Previous studies suggest that lactoferrin can improve barrier function in a variety of contexts. This study set out to dete...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e63da53f-9524-52f7-aae3-3db481d18f3d
- DOI
- 10.1101/2019.12.23.878207
